P2.14-43 Cost-Effectiveness of 1st-Line Treatment EGFR-TKIs for Advanced NSCLC Patients Harboring EGFR Mutation in Mexico

作者：L.A. Ramírez Tirado, S Guzman, C. Goycochea-Robles, Feliciano Barrón, Luis Cabrera‐Miranda, Diana Flores‐Estrada, Óscar Arrieta · 发表于：Journal of Thoracic Oncology · 年份：2019 · DOI：10.1016/j.jtho.2019.08.1828 · 研究领域：Economic and Financial Impacts of Cancer